| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,953 |
3,152 |
$227K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,985 |
2,411 |
$80K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,029 |
704 |
$69K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,141 |
1,100 |
$24K |
| 94644 |
|
670 |
446 |
$20K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,952 |
2,660 |
$17K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
685 |
636 |
$17K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
214 |
210 |
$15K |
| 87070 |
|
1,742 |
1,575 |
$11K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
159 |
134 |
$10K |
| 87184 |
|
1,744 |
1,574 |
$9K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
189 |
189 |
$3K |
| 97803 |
|
409 |
408 |
$3K |
| J7626 |
Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg |
553 |
370 |
$3K |
| 99050 |
|
206 |
171 |
$2K |
| 90656 |
|
33 |
33 |
$296.62 |
| 92567 |
|
14 |
14 |
$150.13 |
| 36410 |
|
35 |
28 |
$108.30 |
| 87081 |
|
17 |
12 |
$89.25 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
12 |
12 |
$83.82 |
| 90713 |
|
15 |
12 |
$0.00 |